Literature DB >> 30068644

Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.

Rehab I Moustafa1,2, Juliano G Haddad1,3, Lydia Linna1, Xavier Hanoulle4, Véronique Descamps5, Ahmed Atef Mesalam6,7,8, Thomas F Baumert9, Gilles Duverlie5, Philip Meuleman6, Jean Dubuisson10, Muriel Lavie10.   

Abstract

In the hepatitis C virus (HCV) envelope glycoproteins E1 and E2, which form a heterodimer, E2 is the receptor binding protein and the major target of neutralizing antibodies, whereas the function of E1 remains less characterized. To investigate E1 functions, we generated a series of mutants in the conserved residues of the C-terminal region of the E1 ectodomain in the context of an infectious clone. We focused our analyses on two regions of interest. The first region is located in the middle of the E1 glycoprotein (between amino acid [aa] 270 and aa 291), which contains a conserved hydrophobic sequence and was proposed to constitute a putative fusion peptide. The second series of mutants was generated in the region from aa 314 to aa 342 (the aa314-342 region), which has been shown to contain two α helices (α2 and α3) by nuclear magnetic resonance studies. Of the 22 generated mutants, 20 were either attenuated or noninfectious. Several mutations modulated the virus's dependence on claudin-1 and the scavenger receptor BI coreceptors for entry. Most of the mutations in the putative fusion peptide region affected virus assembly. Conversely, mutations in the α-helix aa 315 to 324 (315-324) residues M318, W320, D321, and M322 resulted in a complete loss of infectivity without any impact on E1E2 folding and on viral assembly. Further characterization of the W320A mutant in the HCVpp model indicated that the loss of infectivity was due to a defect in viral entry. Together, these results support a role for E1 in modulating HCV interaction with its coreceptors and in HCV assembly. They also highlight the involvement of α-helix 315-324 in a late step of HCV entry.IMPORTANCE HCV is a major public health problem worldwide. The virion harbors two envelope proteins, E1 and E2, which are involved at different steps of the viral life cycle. Whereas E2 has been extensively characterized, the function of E1 remains poorly defined. We characterized here the function of the putative fusion peptide and the region containing α helices of the E1 ectodomain, which had been previously suggested to be important for virus entry. We could confirm the importance of these regions for the virus infectivity. Interestingly, we found several residues modulating the virus's dependence on several HCV receptors, thus highlighting the role of E1 in the interaction of the virus with cellular receptors. Whereas mutations in the putative fusion peptide affected HCV infectivity and morphogenesis, several mutations in the α2-helix region led to a loss of infectivity with no effect on assembly, indicating a role of this region in virus entry.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  envelope proteins; glycoprotein; hepatitis C virus; viral assembly; viral entry

Mesh:

Substances:

Year:  2018        PMID: 30068644      PMCID: PMC6158422          DOI: 10.1128/JVI.00939-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.

Authors:  Budhaditya Mazumdar; Arup Banerjee; Keith Meyer; Ranjit Ray
Journal:  Hepatology       Date:  2011-07-25       Impact factor: 17.425

2.  Glycosylation of the hepatitis C virus envelope protein E1 occurs posttranslationally in a mannosylphosphoryldolichol-deficient CHO mutant cell line.

Authors:  Sandrine Duvet; Anne Op De Beeck; Laurence Cocquerel; Czeslaw Wychowski; René Cacan; Jean Dubuisson
Journal:  Glycobiology       Date:  2002-02       Impact factor: 4.313

3.  Mechanisms of Virus Membrane Fusion Proteins.

Authors:  Margaret Kielian
Journal:  Annu Rev Virol       Date:  2014-06-24       Impact factor: 10.431

4.  Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity.

Authors:  Khaled Alsaleh; Pierre-Yves Delavalle; André Pillez; Gilles Duverlie; Véronique Descamps; Yves Rouillé; Jean Dubuisson; Czeslaw Wychowski
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

5.  Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.

Authors:  Muriel Lavie; Stéphane Sarrazin; Roland Montserret; Véronique Descamps; Thomas F Baumert; Gilles Duverlie; Karin Séron; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

6.  Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein.

Authors:  Roberta Spadaccini; Gerardino D'Errico; Viviana D'Alessio; Eugenio Notomista; Alessia Bianchi; Marcello Merola; Delia Picone
Journal:  Biochim Biophys Acta       Date:  2009-11-03

7.  Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.

Authors:  Ursula Andréo; Patrick Maillard; Olga Kalinina; Marine Walic; Eliane Meurs; Michèle Martinot; Patrick Marcellin; Agata Budkowska
Journal:  Cell Microbiol       Date:  2007-05-21       Impact factor: 3.715

8.  Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.

Authors:  Florian Douam; Viet Loan Dao Thi; Guillemette Maurin; Judith Fresquet; Dimitri Mompelat; Mirjam B Zeisel; Thomas F Baumert; François-Loïc Cosset; Dimitri Lavillette
Journal:  Hepatology       Date:  2014-01-28       Impact factor: 17.425

9.  The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling.

Authors:  Andrew Macdonald; Katherine Crowder; Andrew Street; Christopher McCormick; Kalle Saksela; Mark Harris
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

10.  Global distribution and prevalence of hepatitis C virus genotypes.

Authors:  Jane P Messina; Isla Humphreys; Abraham Flaxman; Anthony Brown; Graham S Cooke; Oliver G Pybus; Eleanor Barnes
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

View more
  2 in total

Review 1.  VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design.

Authors:  Fang Chen; Netanel Tzarum; Ian A Wilson; Mansun Law
Journal:  Curr Opin Virol       Date:  2019-03-16       Impact factor: 7.090

2.  Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening.

Authors:  Jennifer M Pfaff-Kilgore; Edgar Davidson; Kathryn Kadash-Edmondson; Mayda Hernandez; Erin Rosenberg; Ross Chambers; Matteo Castelli; Nicola Clementi; Nicasio Mancini; Justin R Bailey; James E Crowe; Mansun Law; Benjamin J Doranz
Journal:  Cell Rep       Date:  2022-05-24       Impact factor: 9.995

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.